Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA approves AstraZeneca’s faslodex for expanded use in breast cancer

pharmaceutical-technologyAugust 31, 2017

Tag: FDA , AstraZeneca , Breast Cancer

PharmaSources Customer Service